Provided by Tiger Trade Technology Pte. Ltd.

Profound Medical Corp.

6.87
+0.08001.18%
Volume:37.91K
Turnover:263.03K
Market Cap:250.98M
PE:-6.98
High:7.08
Open:6.80
Low:6.80
Close:6.79
52wk High:8.95
52wk Low:3.76
Shares:36.53M
Float Shares:35.45M
Volume Ratio:0.53
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9839
EPS(LYR):-1.4081
ROE:-73.53%
ROA:-39.46%
PB:5.04
PE(LYR):-4.88

Loading ...

Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’

GlobeNewswire
·
Aug 17

Profound Medical CFO Rashed Dewan steps down, Matthew Sobczyk interim CFO

TIPRANKS
·
Aug 16

Profound Medical Names Matthew Sobczyk Interim CFO

MT Newswires Live
·
Aug 15

Profound Medical Announces Management Change

GlobeNewswire
·
Aug 15

Profound Medical Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Profound Medical Q2 EPS $(0.26), Inline, Sales $2.483M Miss $5.500M Estimate

Benzinga Earnings
·
Aug 07

Profound Medical Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 07

Profound Medical Corp Expected to Post a Loss of 24 Cents a Share - Earnings Preview

Reuters
·
Aug 05

Profound Medical Reports New Statistically Significant Tulsa Trial Results; Shares Rise

MT Newswires Live
·
Jul 25

Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial

GlobeNewswire
·
Jul 24

Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow

GlobeNewswire
·
Jul 17

Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026

GlobeNewswire
·
May 14

Profound Medical files to sell 921,428 common shares for holders

TIPRANKS
·
May 13

Profound Medical Q1 EPS $(0.19) Beats $(0.35) Estimate, Sales $5.337M Miss $6.648M Estimate

Benzinga Earnings
·
May 08

Profound Medical Corp expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
May 06

Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow

GlobeNewswire
·
Apr 16

Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference

GlobeNewswire
·
Apr 14

Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting

GlobeNewswire
·
Apr 01

Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone

GlobeNewswire
·
Mar 27

Profound Medical reports CAPTAIN trial meets primary safety endpoint

TIPRANKS
·
Mar 13